title: Psoriasis treatment 2003 at the new millennium: position paper on behalf of the authors.
authors.affiliation: Division of Dermatology, Baylor University Medical Center, Dallas, TX, USA. alan@alanmenter.com
authors.forename: M Alan
authors.initials: MA
authors.lastname: Menter
authors.forename: Gerald C
authors.initials: GC
authors.lastname: Krueger
authors.forename: Steven R
authors.initials: SR
authors.lastname: Feldman
authors.forename: Gerald D
authors.initials: GD
authors.lastname: Weinstein
mesh_terms: D003879:Dermatologic Agents / Q000266:history / Q000627:therapeutic use*; D005544:Forecasting; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D008329:Managed Care Programs; D008727:Methotrexate / Q000266:history / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians'; D011565:Psoriasis / Q000188:drug therapy* / Q000266:history; D011788:Quality of Life
chemical_list: D003879:Dermatologic Agents; D008727:Methotrexate